Robert (Bob) Allen is a marketing professional with a record of accomplishment for strategic planning and developing innovative digital marketing initiatives for brands in pharmaceuticals, CPG, finance, durable goods, and the communications/entertainment industries. He currently leads Digital Operations for Corporate Affairs at Bristol Myers Squibb.
Before joining Bristol Myers Squibb, he led AstraZeneca's Digital Innovation Group (DIG) in the UK. He developed new solutions and collaborations with start-up companies to deliver innovative approaches to making pharmaceutical products and information more relevant and accessible to patients and physicians. Before AstraZeneca, Robert was a Group Vice President at Digitas Health, leading market strategy for various pharmaceutical and OTC brands.
DTC Perspectives recognized Robert as one of the pharmaceutical industries Top 25 Marketers in 2012.